Although it remains to be clarified whether the effects induced by compound 4 are due to increased lipophilicity or other effects mediated by different targets compared to (R)-9-HSA, we have, nevertheless, obtained an effective compound that can not only block cell growth but also reprogram lipid metabolism in colon cancer. The gene discussed is ALB; the disease is malignant colon neoplasm.